BioMarin Pharmaceutical Inc. (BMV:BMRN)

BioMarin Pharmaceutical Statistics

Total Valuation

BMV:BMRN has a market cap or net worth of MXN 191.02 billion. The enterprise value is 174.81 billion.

Market Cap	191.02B
Enterprise Value	174.81B

Important Dates

The last earnings date was Monday, October 27, 2025.

Earnings Date	Oct 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	192.11M
Shares Outstanding	n/a
Shares Change (YoY)	+2.10%
Shares Change (QoQ)	-2.57%
Owned by Insiders (%)	0.78%
Owned by Institutions (%)	91.50%
Float	178.16M

Valuation Ratios

The trailing PE ratio is 20.01 and the forward PE ratio is 10.98.

PE Ratio	20.01
Forward PE	10.98
PS Ratio	3.37
PB Ratio	1.72
P/TBV Ratio	1.85
P/FCF Ratio	12.52
P/OCF Ratio	11.39
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.65, with an EV/FCF ratio of 11.45.

EV / Earnings	18.31
EV / Sales	3.04
EV / EBITDA	11.65
EV / EBIT	13.24
EV / FCF	11.45

Financial Position

The company has a current ratio of 4.83, with a Debt / Equity ratio of 0.10.

Current Ratio	4.83
Quick Ratio	2.84
Debt / Equity	0.10
Debt / EBITDA	0.75
Debt / FCF	0.73
Interest Coverage	66.49

Financial Efficiency

Return on equity (ROE) is 9.07% and return on invested capital (ROIC) is 7.01%.

Return on Equity (ROE)	9.07%
Return on Assets (ROA)	6.15%
Return on Invested Capital (ROIC)	7.01%
Return on Capital Employed (ROCE)	10.44%
Revenue Per Employee	18.67M
Profits Per Employee	3.14M
Employee Count	3,040
Asset Turnover	0.43
Inventory Turnover	0.45

Taxes

In the past 12 months, BMV:BMRN has paid 2.91 billion in taxes.

Income Tax	2.91B
Effective Tax Rate	23.39%

Stock Price Statistics

The stock price has decreased by -41.82% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-41.82%
50-Day Moving Average	1,481.76
200-Day Moving Average	1,631.51
Relative Strength Index (RSI)	32.78
Average Volume (20 Days)	111

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.51

Income Statement

In the last 12 months, BMV:BMRN had revenue of MXN 56.75 billion and earned 9.55 billion in profits. Earnings per share was 49.17.

Revenue	56.75B
Gross Profit	46.15B
Operating Income	13.05B
Pretax Income	12.46B
Net Income	9.55B
EBITDA	14.56B
EBIT	13.05B
Earnings Per Share (EPS)	49.17

Balance Sheet

The company has 27.11 billion in cash and 11.08 billion in debt, giving a net cash position of 16.02 billion.

Cash & Cash Equivalents	27.11B
Total Debt	11.08B
Net Cash	16.02B
Net Cash Per Share	n/a
Equity (Book Value)	111.09B
Book Value Per Share	578.31
Working Capital	56.06B

Cash Flow

In the last 12 months, operating cash flow was 16.76 billion and capital expenditures -1.50 billion, giving a free cash flow of 15.26 billion.

Operating Cash Flow	16.76B
Capital Expenditures	-1.50B
Free Cash Flow	15.26B
FCF Per Share	n/a

Margins

Gross margin is 81.32%, with operating and profit margins of 22.99% and 16.82%.

Gross Margin	81.32%
Operating Margin	22.99%
Pretax Margin	21.95%
Profit Margin	16.82%
EBITDA Margin	25.66%
EBIT Margin	22.99%
FCF Margin	26.89%

Dividends & Yields

BMV:BMRN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.10%
Shareholder Yield	-2.10%
Earnings Yield	5.00%
FCF Yield	7.99%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:BMRN has an Altman Z-Score of 5.84 and a Piotroski F-Score of 7.

Altman Z-Score	5.84
Piotroski F-Score	7